GlaxoSmithKline PLC agreed Thursday to release negative data on the safety and effectiveness of its drugs to settle a lawsuit by New York's attorney general that accused the pharmaceutical maker of misrepresenting data on prescribing its antidepressant drug Paxil to children. The company is the first major drug maker to agree to disclose all its studies. It will also pay $2.5 million to the state as part of the settlement.
August 27, 2004 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
The Partners Group is currently recruiting a VP of Legal for our burgeoning client, a real estate investment firm in Atlanta, GA. The firm h...
The United States Court of Appeals for the Tenth Circuit seeks applications for a bankruptcy judgeship in the District of Utah. Bankruptcy ...
Harter Secrest and Emery is seeking a securities and capital markets attorney, senior associate or counsel level, with eight or more years o...
